logo

Progenics Pharmaceuticals Inc (PGNX)



Trade PGNX now with
  Date
  Headline
6/19/2019 8:40:39 AM Progenics Urges Shareholders To Vote “For” All Of Company’s Directors On The WHITE Proxy Card
6/13/2019 8:43:08 AM Progenics Doses First Patient In Phase 2 Clinical Study Of 1095 Radiotherapy
1/3/2019 1:31:32 AM Progenics And Curium Announce European Collaboration For Prostate Cancer Imaging Agent PyL
11/8/2018 7:42:35 AM Progenics Pharma Q3 Net Loss $24.4 Mln Or $0.30/Shr Vs Loss Of $15.4 Mln Or $0.22/Shr Last Year
10/5/2018 7:32:30 AM Progenics Announces Data From Its OSPREY 2301 Study Of PyL
9/17/2018 6:03:40 AM Progenics Adds AZEDRA To National Comprehensive Cancer Network Guidelines For Pheochromocytoma And Paraganglioma
8/7/2018 11:00:17 PM Progenics Pharma Prices Underwritten Public Offering Of 9.09 Mln Shares At $8.25/shr
6/26/2018 8:37:15 AM Progenics Completes Enrollment Of Phase 2/3 Trial Of PSMA-Targeted PET/CT Imaging Agent PyL In Prostate Cancer
6/8/2018 7:00:35 AM Amicus Therapeutics Appoints President And COO Bradley Campbell To Board
6/4/2018 8:39:28 AM Progenics Announces Presentation Of Updated Data From Pivotal Trial Of AZEDRA